<?xml version="1.0" encoding="utf-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:types="http://xbrl.frc.org.uk/general/2019-01-01/types" xmlns:uk-ref="http://xbrl.frc.org.uk/general/2019-01-01/ref" xmlns:common="http://xbrl.frc.org.uk/general/2019-01-01/common" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:curr="http://xbrl.frc.org.uk/cd/2019-01-01/currencies" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:countries="http://xbrl.frc.org.uk/cd/2019-01-01/countries" xmlns:lang="http://xbrl.frc.org.uk/cd/2019-01-01/languages" xmlns:bus="http://xbrl.frc.org.uk/cd/2019-01-01/business" xmlns:accrep="http://xbrl.frc.org.uk/reports/2019-01-01/accrep" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:aurep="http://xbrl.frc.org.uk/reports/2019-01-01/aurep" xmlns:Q1="http://xbrl.org/2005/xbrldt" xmlns:direp="http://xbrl.frc.org.uk/reports/2019-01-01/direp" xmlns:core="http://xbrl.frc.org.uk/fr/2019-01-01/core" xmlns:FRS-102="http://xbrl.frc.org.uk/FRS-102/2019-01-01" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2010-04-20" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="application/xhtml+xml; charset=UTF-8" http-equiv="Content-Type" /><title>VENN_HEALTHCARE_LIMITED - Accounts</title><style type="text/css">@page land { size:landscape; }@page port { size:portrait; }.pageFirst { page-break-after:always;  background-color:white;    border-top:1px solid black;  border-bottom:1px solid black;    border-left:1px solid black;    border-right:1px solid black;   } .portraitPage {    page:port;  width:21cm; height:29.7cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } .landscapePage {  page:land;  width:29.7cm; height:21cm; page-break-after:always; background-color:white; border-top:1px solid black; border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; position:relative; } a.tooltip {color:black;text-decoration:none}a.tooltip span{display:none}a.tooltip:hover span{display:inline;position:absolute;z-index:5002;background:#ffffff}a.anchor {color:blue;}a.tooltipRTF {color:black;text-decoration:none;display:none}span:hover a.tooltipRTF {display:block;position:absolute;background:#ffffff}span.tooltipRTFtext {position:absolute;left:10;width:200;border:1pt solid black;text-align:left;font-weight:normal;z-index:5002;bottom:20;font-family:Arial;font-size:9;background-color:#FFFFCC; }.c,.crn,.cjn,.cln,.ccn,.crb,.cjb,.clb,.ccb,.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{position:absolute;word-wrap:break-word}.crn,.cjn,.cln,.ccn,.crni,.cjni,.clni,.ccni{font-weight:normal}.crb,.clb,.cjb,.ccb,.crbi,.cjbi,.clbi,.ccbi{font-weight:bold}.crni,.cjni,.clni,.ccni,.crbi,.cjbi,.clbi,.ccbi{font-style:italic}.crn,.crb,.crni,.crbi{text-align:right}.cln,.clb,.clni,.clbi{text-align:left}.ccn,.ccb,.ccni,.ccbi{text-align:center}.cjn,.cjb,.cjni,.cjbi{text-align:justify}.fn0{font-size:0px}.fn1{font-size:10.4px;font-family:Arial}.fn2{font-size:15.2px;font-family:Arial}.fn3{font-size:12.8px;font-family:Arial}.fn4{font-size:6.4px;font-family:Arial}.fn5{font-size:9.6px;font-family:Arial}.fn6{font-size:0px;font-family:Arial}.sln{border-top:1px solid black}.dln{border-top:4px double black}.u{text-decoration:underline}ul,li{ margin-top:0px;margin-bottom:0px;margin-right:0px;margin-left:8px;   padding-top:0px;padding-bottom:0px;padding-right:0px;padding-left:8px;} </style></head><body xml:lang="en" style="background-color:white"><div class="pageFirst" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="crb fn1" style="top:52.31pt;left:43.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:CountryFormationOrIncorporation"></ix:nonNumeric>Company Registration No. <ix:nonNumeric contextRef="C" name="bus:UKCompaniesHouseRegisteredNumber">09187373</ix:nonNumeric> (England and Wales)</div><div class="ccb fn2" style="top:162.17pt;left:46.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="ccb fn2" style="top:188.45pt;left:46.61pt;width:420.55pt;"><ix:nonNumeric contextRef="C" name="bus:ReportTitle">UNAUDITED FINANCIAL STATEMENTS</ix:nonNumeric></div><div class="ccb fn2" style="top:214.74pt;left:46.61pt;width:420.55pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="ccb fn2" style="top:241.12pt;left:46.61pt;width:420.55pt;">PAGES FOR FILING WITH REGISTRAR</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">CONTENTS</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:98.82pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:123.45pt;left:409.6pt;width:60.79pt;">Page</div><div class="cln fn1" style="top:156.46pt;left:46.61pt;width:362.98pt;">Balance sheet</div><div class="cln fn1" style="top:156.46pt;left:409.6pt;width:57.79pt;">1</div><div class="cln fn1" style="top:200.49pt;left:46.61pt;width:362.98pt;">Notes to the financial statements</div><div class="cln fn1" style="top:200.49pt;left:409.6pt;width:57.79pt;">2 - 7</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">BALANCE SHEET </div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">AS AT <div style="display:inline">30 JUNE 2019<div style="display:none"><ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="bus:BalanceSheetDate">30 June 2019</ix:nonNumeric></div></div></div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 1 -</div><div class="clb fn1" style="top:122.11pt;left:296.45pt;width:59.56pt;">2019</div><div class="clb fn1" style="top:122.11pt;left:409.57pt;width:59.55pt;">2018</div><div class="ccb fn1" style="top:133.12pt;left:199.49pt;width:43.39pt;">Notes</div><div class="crb fn1" style="top:133.12pt;left:236.88pt;width:59.56pt;">£</div><div class="crb fn1" style="top:133.12pt;left:293.45pt;width:59.56pt;">£</div><div class="crb fn1" style="top:133.12pt;left:350.01pt;width:59.55pt;">£</div><div class="crb fn1" style="top:133.12pt;left:406.57pt;width:59.55pt;">£</div><div class="cln fn6" style="top:133.12pt;left:466.77pt;width:0.65pt;"></div><div class="clb fn1" style="top:155.13pt;left:46.61pt;width:365.95pt;">Fixed assets</div><div class="cln fn1" style="top:166.14pt;left:46.61pt;width:152.88pt;">Intangible assets</div><div class="crn fn1" style="top:166.14pt;left:296.45pt;width:56.56pt;">-</div><div class="crn fn1" style="top:166.14pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="F" decimals="0" scale="0" unitRef="GBP" name="core:DividendsPaidOnShares">162</ix:nonFraction></div><div class="cln fn1" style="top:177.14pt;left:46.61pt;width:152.88pt;">Tangible assets</div><div class="ccb fn1" style="top:177.14pt;left:199.49pt;width:43.39pt;">4</div><div class="crn fn1" style="top:177.14pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">16,614</ix:nonFraction></div><div class="crn fn1" style="top:177.14pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">17,497</ix:nonFraction></div><div class="clb fn1" style="top:199.16pt;left:46.61pt;width:196.27pt;">Current assets</div><div class="cln fn1" style="top:210.16pt;left:46.61pt;width:152.88pt;">Stocks</div><div class="ccb fn1" style="top:210.16pt;left:199.49pt;width:43.39pt;"></div><div class="crn fn1" style="top:210.16pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalInventories">606,495</ix:nonFraction></div><div class="crn fn1" style="top:210.16pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalInventories">318,374</ix:nonFraction></div><div class="cln fn1" style="top:221.17pt;left:46.61pt;width:152.88pt;">Debtors</div><div class="ccb fn1" style="top:221.17pt;left:199.49pt;width:43.39pt;">5</div><div class="crn fn1" style="top:221.17pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">990,436</ix:nonFraction></div><div class="crn fn1" style="top:221.17pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Debtors">804,041</ix:nonFraction></div><div class="cln fn1" style="top:232.17pt;left:46.61pt;width:152.88pt;">Cash at bank and in hand</div><div class="crn fn1" style="top:232.17pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CashBankOnHand">35,041</ix:nonFraction></div><div class="crn fn1" style="top:232.17pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CashBankOnHand">107,768</ix:nonFraction></div><div class="cln fn0 sln" style="top:248.02pt;left:259pt;width:37.45pt;"></div><div class="cln fn0 sln" style="top:248.02pt;left:372.12pt;width:37.45pt;"></div><div class="crn fn1" style="top:254.19pt;left:239.88pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CurrentAssets">1,631,972</ix:nonFraction></div><div class="crn fn1" style="top:254.19pt;left:353.01pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:CurrentAssets">1,230,183</ix:nonFraction></div><div class="clb fn1" style="top:265.19pt;left:46.61pt;width:155.88pt;">Creditors: amounts falling due within one year</div><div class="ccb fn1" style="top:274.87pt;left:199.49pt;width:43.39pt;"></div><div class="crn fn1" style="top:274.87pt;left:242.69pt;width:56.56pt;">(<ix:nonFraction contextRef="B_DG_EF" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">1,161,241</ix:nonFraction>)</div><div class="crn fn1" style="top:274.87pt;left:355.81pt;width:56.55pt;">(<ix:nonFraction contextRef="E_DG_EF" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Creditors">849,629</ix:nonFraction>)</div><div class="cln fn0 sln" style="top:290.71pt;left:259pt;width:37.45pt;"></div><div class="cln fn0 sln" style="top:290.71pt;left:372.12pt;width:37.45pt;"></div><div class="clb fn1" style="top:296.88pt;left:46.61pt;width:252.84pt;">Net current assets</div><div class="crn fn1" style="top:296.88pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">470,731</ix:nonFraction></div><div class="crn fn1" style="top:296.88pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:NetCurrentAssetsLiabilities">380,554</ix:nonFraction></div><div class="cln fn0 sln" style="top:312.73pt;left:315.56pt;width:37.45pt;"></div><div class="cln fn0 sln" style="top:312.73pt;left:428.67pt;width:37.45pt;"></div><div class="clb fn1" style="top:318.9pt;left:46.61pt;width:196.27pt;">Total assets less current liabilities</div><div class="crn fn1" style="top:318.9pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAssetsLessCurrentLiabilities">487,345</ix:nonFraction></div><div class="crn fn1" style="top:318.9pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAssetsLessCurrentLiabilities">398,213</ix:nonFraction></div><div class="cln fn0 dln" style="top:334.74pt;left:315.56pt;width:37.45pt;"></div><div class="cln fn0 dln" style="top:334.74pt;left:428.67pt;width:37.45pt;"></div><div class="clb fn1" style="top:351.92pt;left:46.61pt;width:155.88pt;">Capital and reserves</div><div class="cln fn1" style="top:362.92pt;left:46.61pt;width:152.88pt;">Called up share capital</div><div class="ccb fn1" style="top:362.92pt;left:199.49pt;width:43.39pt;">6</div><div class="crn fn1" style="top:362.92pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B_EG_EH" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">400,150</ix:nonFraction></div><div class="crn fn1" style="top:362.92pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E_EG_EH" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">400,150</ix:nonFraction></div><div class="cln fn1" style="top:373.93pt;left:46.61pt;width:152.88pt;">Profit and loss reserves</div><div class="ccb fn1" style="top:373.93pt;left:199.49pt;width:43.39pt;"></div><div class="crn fn1" style="top:373.93pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B_EG_EI" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">87,195</ix:nonFraction></div><div class="crn fn1" style="top:373.93pt;left:412.37pt;width:56.55pt;">(<ix:nonFraction contextRef="E_EG_EI" decimals="0" scale="0" unitRef="GBP" sign="-" format="ixt:numcommadot" name="core:Equity">1,937</ix:nonFraction>)</div><div class="cln fn0 sln" style="top:389.77pt;left:315.56pt;width:37.45pt;"></div><div class="cln fn0 sln" style="top:389.77pt;left:428.67pt;width:37.45pt;"></div><div class="clb fn1" style="top:395.94pt;left:46.61pt;width:196.27pt;">Total equity</div><div class="crn fn1" style="top:395.94pt;left:296.45pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">487,345</ix:nonFraction></div><div class="crn fn1" style="top:395.94pt;left:409.57pt;width:56.55pt;"><ix:nonFraction contextRef="E" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">398,213</ix:nonFraction></div><div class="cln fn0 dln" style="top:411.78pt;left:315.56pt;width:37.45pt;"></div><div class="cln fn0 dln" style="top:411.78pt;left:428.67pt;width:37.45pt;"></div><div class="cln" style="top:429pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:EntityHasTakenExemptionUnderCompaniesActInNotPublishingItsOwnProfitLossAccountTruefalse"><span class="fn1"><ix:exclude>The director of the company has elected not to include a copy of the profit and loss account within the financial statements.</ix:exclude><span style="display:none">true</span></span></ix:nonNumeric></p></div><div class="cln" style="top:461pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatCompanyEntitledToExemptionFromAuditUnderSection477CompaniesAct2006RelatingToSmallCompanies"><span class="fn1">For the financial year ended 30 June 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.</span></ix:nonNumeric></p></div><div class="cln" style="top:492pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatDirectorsAcknowledgeTheirResponsibilitiesUnderCompaniesAct"><span class="fn1">The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.</span></ix:nonNumeric></p></div><div class="cln" style="top:524pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatMembersHaveNotRequiredCompanyToObtainAnAudit" continuedAt="C_FK_0"><span class="fn1">T</span></ix:nonNumeric><span class="fn1"></span><ix:continuation id="C_FK_0" continuedAt="C_FK_1"><span class="fn1">he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FK_1"><span class="fn1">.</span></ix:continuation></p></div><div class="cln" style="top:555pt;left:47pt;width:420pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="direp:StatementThatAccountsHaveBeenPreparedInAccordanceWithProvisionsSmallCompaniesRegime"><span class="fn1">These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.</span></ix:nonNumeric></p></div><div class="cjn fn1" style="top:587pt;left:46.61pt;width:419.51pt;">The financial statements were approved and signed by the director and authorised for issue on <ix:nonNumeric contextRef="B" format="ixt:datelonguk" name="core:DateAuthorisationFinancialStatementsForIssue">31 March 2020</ix:nonNumeric></div><div class="cln fn1" style="top:631.02pt;left:46.61pt;width:419.51pt;"><ix:nonNumeric contextRef="C_EJ_EK" name="core:DirectorSigningFinancialStatements"></ix:nonNumeric>C Schiel</div><div class="clb fn1" style="top:642.03pt;left:46.61pt;width:422.51pt;">Director</div><div class="clb fn1" style="top:664.04pt;left:46.61pt;width:422.51pt;">Company Registration No. 09187373</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS </div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 2 -</div><div class="clb fn1" style="top:122.11pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn1" style="top:122.11pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="cln fn6" style="top:122.11pt;left:466.79pt;width:0.65pt;"></div><div class="clb fn1" style="top:144.12pt;left:67.73pt;width:401.41pt;">Company information</div><div class="cln" style="top:155pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Venn Healthcare Limited is a</span><span class="fn1"> private </span><span class="fn1">company</span><span class="fn1"> limited by shares</span><span class="fn1"> incorporated in England and Wales.</span><span class="fn1"> </span><span class="fn1">The registered office is</span><span class="fn1"> Finsgate, 5-7 Cranwood Street, London, EC1V 9EE.</span></p></div><div class="clb fn1" style="top:186.83pt;left:46.61pt;width:24.12pt;">1.1</div><div class="clb fn1" style="top:186.83pt;left:67.73pt;width:401.41pt;">Accounting convention</div><div class="cln" style="top:198pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:StatementComplianceWithApplicableReportingFramework"><span class="fn1">These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.</span></ix:nonNumeric></p></div><div class="cln" style="top:258pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">The financial statements are prepared in</span><span class="fn1"> sterling</span><span class="fn1">, which is the functional currency of the company. </span><span class="fn1">Monetary a</span><span class="fn1">mounts </span><span class="fn1">in these financial statements are </span><span class="fn1">rounded to the nearest £.</span></p></div><div class="cln" style="top:290pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:GeneralDescriptionBasisMeasurementUsedInPreparingFinancialStatements"><span class="fn1">The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.</span></ix:nonNumeric></p></div><div class="clb fn1" style="top:321.31pt;left:46.61pt;width:24.12pt;">1.2</div><div class="clb fn1" style="top:321.31pt;left:67.73pt;width:401.41pt;">Turnover</div><div class="cln" style="top:332pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:RevenueRecognitionPolicy" continuedAt="C_FL_0"><span class="fn1">Turnover represents amounts receivable for services net of VAT.</span></ix:nonNumeric></p></div><div class="cln" style="top:354pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FL_0" continuedAt="C_FL_1"><span class="fn1">Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FL_1" continuedAt="C_FL_2"><span class="fn1"> (usually on dispatch of the goods)</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FL_2"><span class="fn1">, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.</span></ix:continuation></p></div><div class="clb fn1" style="top:404.95pt;left:46.61pt;width:24.12pt;">1.3</div><div class="clb fn1" style="top:404.95pt;left:67.73pt;width:401.41pt;">Intangible fixed assets other than goodwill</div><div class="cln" style="top:416pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C_EM_EN" name="core:DescriptionRecognitionBasisMeasurementIntangibleAssets" continuedAt="C_FM_0"><span class="fn1">Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses. </span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FM_0" continuedAt="C_FM_1"><span class="fn1">Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FM_1" continuedAt="C_FM_2"><span class="fn1">where </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FM_2" continuedAt="C_FM_3"><span class="fn1">it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FM_3" continuedAt="C_FM_4"><span class="fn1">fair </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FM_4"><span class="fn1">value of the asset can be measured reliably.</span></ix:continuation></p></div><div class="cln" style="top:486pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:DescriptionAmortisationMethodForIntangibleAssets"><span class="fn1">Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:</span></ix:nonNumeric></p></div><div class="cln fn1" style="top:518.05pt;left:67.73pt;width:172.16pt;">Website development costs</div><div class="cln fn1" style="top:518.05pt;left:239.9pt;width:227.49pt;">Over estimated useful life of 5 years</div><div class="clb fn1" style="top:540.06pt;left:46.61pt;width:24.12pt;">1.4</div><div class="clb fn1" style="top:540.06pt;left:67.73pt;width:401.41pt;">Tangible fixed assets</div><div class="cln" style="top:551pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:DescriptionMeasurementBasisForPropertyPlantEquipment" continuedAt="C_FN_0"><span class="fn1">Tangible fixed assets </span></ix:nonNumeric><span class="fn1"></span><ix:continuation id="C_FN_0"><span class="fn1">are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.</span></ix:continuation></p></div><div class="cln" style="top:582pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:nonNumeric contextRef="C" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment"><span class="fn1">Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:</span></ix:nonNumeric></p></div><div class="cln fn1" style="top:614.03pt;left:67.73pt;width:172.16pt;">Computer equipment</div><div class="cln fn1" style="top:614.03pt;left:239.9pt;width:227.49pt;"><ix:nonNumeric contextRef="C_CX_ER" name="core:DescriptionDepreciationMethodForPropertyPlantEquipment">33% Reducing balance</ix:nonNumeric></div><div class="cln fn1" style="top:625.03pt;left:67.73pt;width:172.16pt;">Motor vehicles</div><div class="cln fn1" style="top:625.03pt;left:239.9pt;width:227.49pt;">20% Reducing balance</div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:121.45pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn1" style="top:121.45pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn1" style="top:121.45pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 3 -</div><div class="clb fn1" style="top:144.12pt;left:46.61pt;width:24.12pt;">1.5</div><div class="clb fn1" style="top:144.12pt;left:67.73pt;width:401.41pt;">Stocks</div><div class="cln" style="top:155pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:InventoriesPolicy" continuedAt="C_FO_0"><span class="fn1">Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.</span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FO_0" continuedAt="C_FO_1"><span class="fn1">Stocks held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.</span></ix:continuation></p></div><div class="cln" style="top:225pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FO_1"><span class="fn1">At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.</span></ix:continuation></p></div><div class="clb fn1" style="top:266.48pt;left:46.61pt;width:24.12pt;">1.6</div><div class="clb fn1" style="top:266.48pt;left:67.73pt;width:401.41pt;">Cash and cash equivalents</div><div class="cln" style="top:277pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:CashCashEquivalentsPolicy" continuedAt="C_FP_0"><span class="fn1">Cash and cash equivalents</span></ix:nonNumeric><span class="fn1"> </span><ix:continuation id="C_FP_0" continuedAt="C_FP_1"><span class="fn1">are basic financial assets</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FP_1" continuedAt="C_FP_2"><span class="fn1"> and</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FP_2"><span class="fn1"> include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.</span></ix:continuation></p></div><div class="clb fn1" style="top:318.64pt;left:46.61pt;width:24.12pt;">1.7</div><div class="clb fn1" style="top:318.64pt;left:67.73pt;width:401.41pt;">Financial instruments</div><div class="cln" style="top:330pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:FinancialInstrumentsClassificationPolicy" continuedAt="C_FQ_0"><span class="fn1">The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. </span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FQ_0" continuedAt="C_FQ_1"><span class="fn1">Financial instruments are recognised in the company&apos;s balance sheet when the company becomes party to the contractual provisions of the instrument.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FQ_1" continuedAt="C_FQ_2"><span class="fn1">Financial assets and liabilities are offset</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FQ_2" continuedAt="C_FQ_3"><span class="fn1">, with</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FQ_3" continuedAt="C_FQ_4"><span class="fn1"> the net amounts presented in the financial statements</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FQ_4" continuedAt="C_FQ_5"><span class="fn1">,</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FQ_5"><span class="fn1"> when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.</span></ix:continuation></p></div><div class="clbi fn1" style="top:428.78pt;left:67.73pt;width:344.85pt;">Basic financial assets</div><div class="cln" style="top:440pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest</span><span class="fn1"> </span><span class="fn1">method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.</span><span class="fn1"> Financial assets classified as receivable within one year are not amortised.</span></p></div><div class="clbi fn1" style="top:500.08pt;left:67.73pt;width:401.41pt;">Impairment of financial assets</div><div class="cln" style="top:511pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:ImpairmentFinancialAssetsPolicy" continuedAt="C_FR_0"><span class="fn1">Financial assets, other than those </span></ix:nonNumeric><span class="fn1"></span><ix:continuation id="C_FR_0" continuedAt="C_FR_1"><span class="fn1">held </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FR_1" continuedAt="C_FR_2"><span class="fn1">at </span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FR_2" continuedAt="C_FR_3"><span class="fn1">fair value through profit and loss</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FR_3" continuedAt="C_FR_4"><span class="fn1">, are assessed for indicators of impairment at each reporting end date.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FR_4" continuedAt="C_FR_5"><span class="fn1">Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected.</span></ix:continuation><span class="fn1"></span><ix:continuation id="C_FR_5" continuedAt="C_FR_6"><span class="fn1"> If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FR_6"><span class="fn1">If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.</span></ix:continuation></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:121.45pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn1" style="top:121.45pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn1" style="top:121.45pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 4 -</div><div class="clbi fn1" style="top:144.02pt;left:67.73pt;width:401.41pt;">Derecognition of financial assets</div><div class="cln" style="top:155pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when </span><span class="fn1">the company</span><span class="fn1"> transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.</span></p></div><div class="clbi fn1" style="top:215.32pt;left:67.73pt;width:401.41pt;">Classification of financial liabilities</div><div class="cln" style="top:226pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.</span></p></div><div class="clbi fn1" style="top:267.27pt;left:67.73pt;width:401.41pt;">Basic financial liabilities</div><div class="cln" style="top:278pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Basic financial liabilities, including creditors, bank loans, loans from</span><span class="fn1"> </span><span class="fn1">fellow group companies and preference shares that are classified as debt, are</span><span class="fn1"> </span><span class="fn1">initially recognised at transaction price unless the arrangement constitutes a</span><span class="fn1"> </span><span class="fn1">financing transaction, where the debt instrument is measured at the present value of</span><span class="fn1"> </span><span class="fn1">the future </span><span class="fn1">paymen</span><span class="fn1">ts discounted at a market rate of interest.</span><span class="fn1"> Financial liabilities classified as payable within one year are not amortised.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Debt instruments are subsequently carried at amortised cost, using the effective</span><span class="fn1"> </span><span class="fn1">interest rate method.</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Trade creditors</span><span class="fn1"> are obligations to pay for goods or services that have been acquired</span><span class="fn1"> </span><span class="fn1">in the ordinary course of business from suppliers. A</span><span class="fn1">m</span><span class="fn1">ounts payable are classified as</span><span class="fn1"> </span><span class="fn1">current liabilities if payment is due within one year or less. If not, they are presented</span><span class="fn1"> </span><span class="fn1">as non-current liabilities. Trade creditors are recognised initially at transaction price</span><span class="fn1"> </span><span class="fn1">and subsequently measured at amortised cost using the effective interest method.</span></p></div><div class="clbi fn1" style="top:406.33pt;left:67.73pt;width:401.41pt;">Derecognition of financial liabilities</div><div class="cln" style="top:417pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Financial liabilities are derecognised when the company’s contractual obligations </span><span class="fn1">expire or are discharged or cancelled.</span></p></div><div class="clb fn1" style="top:448.71pt;left:46.61pt;width:24.12pt;">1.8</div><div class="clb fn1" style="top:448.71pt;left:67.73pt;width:401.41pt;">Equity instruments</div><div class="cln" style="top:460pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.</span></p></div><div class="cln" style="top:501pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.</span></p></div><div class="clb fn1" style="top:542.03pt;left:46.61pt;width:24.12pt;">1.9</div><div class="clb fn1" style="top:542.03pt;left:67.73pt;width:401.41pt;">Employee benefits</div><div class="cln" style="top:553pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:EmployeeBenefitsPolicy" continuedAt="C_FS_0"><span class="fn1">The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.  </span></ix:nonNumeric></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FS_0" continuedAt="C_FS_1"><span class="fn1">The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.</span></ix:continuation></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">&#160;</span></p><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:continuation id="C_FS_1"><span class="fn1">Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.</span></ix:continuation></p></div><div class="clb fn1" style="top:642.59pt;left:46.61pt;width:24.12pt;">1.10</div><div class="clb fn1" style="top:642.59pt;left:67.73pt;width:401.41pt;">Retirement benefits</div><div class="cln" style="top:653pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Justify;"><ix:nonNumeric contextRef="C" name="core:DefinedContributionPensionsPolicy"><span class="fn1">Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.</span></ix:nonNumeric></p></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:121.45pt;left:46.61pt;width:24.12pt;">1</div><div class="clb fn1" style="top:121.45pt;left:67.73pt;width:401.41pt;">Accounting policies</div><div class="crb fn1" style="top:121.45pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 5 -</div><div class="clb fn1" style="top:144.12pt;left:46.61pt;width:24.12pt;">1.11</div><div class="clb fn1" style="top:144.12pt;left:67.73pt;width:401.41pt;">Foreign exchange</div><div class="cln" style="top:155pt;left:68pt;width:398pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><ix:nonNumeric contextRef="C" name="core:ForeignCurrencyTranslationOperationsPolicy"><span class="fn1">Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation are included in the profit and loss account for the period.</span></ix:nonNumeric></p></div><div class="clb fn1" style="top:216.97pt;left:46.61pt;width:24.12pt;">2</div><div class="clb fn1" style="top:216.97pt;left:67.73pt;width:402.65pt;">Employees</div><div class="cln" style="top:239pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">The average monthly number of persons (including directors) employed by the company during the year was 5 (2018 - 4).</span></p></div><div class="clb fn1" style="top:281.69pt;left:46.61pt;width:24.12pt;">3</div><div class="clb fn1" style="top:281.69pt;left:67.73pt;width:344.84pt;">Intangible fixed assets</div><div class="cln fn6" style="top:281.69pt;left:410.22pt;width:0.65pt;"></div><div class="crb fn1" style="top:292.7pt;left:356.85pt;width:110.53pt;">Other</div><div class="crb fn1" style="top:303.7pt;left:356.85pt;width:110.53pt;">£</div><div class="clb fn1" style="top:314.71pt;left:67.73pt;width:344.84pt;">Cost</div><div class="cln fn1" style="top:325.71pt;left:67.73pt;width:292.12pt;">At 1 July 2018 and 30 June 2019</div><div class="crn fn1" style="top:325.71pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="A_EM_EN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:IntangibleAssetsGrossCost">5,500</ix:nonFraction></div><div class="cln fn0 sln" style="top:341.56pt;left:446.32pt;width:21.06pt;"></div><div class="clb fn1" style="top:347.73pt;left:67.73pt;width:344.84pt;">Amortisation and impairment</div><div class="cln fn1" style="top:358.73pt;left:67.73pt;width:292.12pt;">At 1 July 2018</div><div class="crn fn1" style="top:358.73pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="A_EM_EN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedAmortisationImpairmentIntangibleAssets">5,338</ix:nonFraction></div><div class="cln fn1" style="top:369.74pt;left:67.73pt;width:292.12pt;">Amortisation charged for the year</div><div class="crn fn1" style="top:369.74pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="C_EM_EN" decimals="0" scale="0" unitRef="GBP" name="core:IncreaseFromAmortisationChargeForYearIntangibleAssets">162</ix:nonFraction></div><div class="cln fn0 sln" style="top:385.58pt;left:446.32pt;width:21.06pt;"></div><div class="cln fn1" style="top:391.75pt;left:67.73pt;width:292.12pt;">At 30 June 2019</div><div class="crn fn1" style="top:391.75pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="B_EM_EN" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedAmortisationImpairmentIntangibleAssets">5,500</ix:nonFraction></div><div class="cln fn0 sln" style="top:407.59pt;left:446.32pt;width:21.06pt;"></div><div class="clb fn1" style="top:413.76pt;left:67.73pt;width:344.84pt;">Carrying amount</div><div class="cln fn1" style="top:424.77pt;left:67.73pt;width:292.12pt;">At 30 June 2019</div><div class="crn fn1" style="top:424.77pt;left:359.85pt;width:107.53pt;">-</div><div class="cln fn0 dln" style="top:440.61pt;left:446.32pt;width:21.06pt;"></div><div class="cln fn1" style="top:446.78pt;left:67.73pt;width:292.12pt;">At 30 June 2018</div><div class="crn fn1" style="top:446.78pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="E_EM_EN" decimals="0" scale="0" unitRef="GBP" name="core:IntangibleAssets">162</ix:nonFraction></div><div class="cln fn0 dln" style="top:462.63pt;left:446.32pt;width:21.06pt;"></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 6 -</div><div class="clb fn1" style="top:122.11pt;left:46.61pt;width:24.12pt;">4</div><div class="clb fn1" style="top:122.11pt;left:67.73pt;width:344.84pt;">Tangible fixed assets</div><div class="cln fn6" style="top:122.11pt;left:410.22pt;width:0.65pt;"></div><div class="crb fn1" style="top:133.12pt;left:356.85pt;width:110.53pt;">Plant and machinery etc</div><div class="crb fn1" style="top:144.12pt;left:356.85pt;width:110.53pt;">£</div><div class="clb fn1" style="top:155.13pt;left:67.73pt;width:344.84pt;">Cost</div><div class="cln fn1" style="top:166.14pt;left:67.73pt;width:292.12pt;">At 1 July 2018</div><div class="crn fn1" style="top:166.14pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="A_CX_ES" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">19,409</ix:nonFraction></div><div class="cln fn1" style="top:177.14pt;left:67.73pt;width:292.12pt;">Additions</div><div class="crn fn1" style="top:177.14pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="C_CX_ES" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TotalAdditionsIncludingFromBusinessCombinationsPropertyPlantEquipment">3,218</ix:nonFraction></div><div class="cln fn0 sln" style="top:192.99pt;left:436.96pt;width:30.43pt;"></div><div class="cln fn1" style="top:199.16pt;left:67.73pt;width:292.12pt;">At 30 June 2019</div><div class="crn fn1" style="top:199.16pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="B_CX_ES" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipmentGrossCost">22,627</ix:nonFraction></div><div class="cln fn0 sln" style="top:215pt;left:436.96pt;width:30.43pt;"></div><div class="clb fn1" style="top:221.17pt;left:67.73pt;width:295.12pt;">Depreciation and impairment</div><div class="cln fn1" style="top:232.17pt;left:67.73pt;width:292.12pt;">At 1 July 2018</div><div class="crn fn1" style="top:232.17pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="A_CX_ES" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">1,912</ix:nonFraction></div><div class="cln fn1" style="top:243.18pt;left:67.73pt;width:292.12pt;">Depreciation charged in the year</div><div class="crn fn1" style="top:243.18pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="C_CX_ES" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:IncreaseFromDepreciationChargeForYearPropertyPlantEquipment">4,101</ix:nonFraction></div><div class="cln fn0 sln" style="top:259.03pt;left:436.96pt;width:30.43pt;"></div><div class="cln fn1" style="top:265.19pt;left:67.73pt;width:292.12pt;">At 30 June 2019</div><div class="crn fn1" style="top:265.19pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="B_CX_ES" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AccumulatedDepreciationImpairmentPropertyPlantEquipment">6,013</ix:nonFraction></div><div class="cln fn0 sln" style="top:281.04pt;left:436.96pt;width:30.43pt;"></div><div class="clb fn1" style="top:287.21pt;left:67.73pt;width:344.84pt;">Carrying amount</div><div class="cln fn1" style="top:298.21pt;left:67.73pt;width:292.12pt;">At 30 June 2019</div><div class="crn fn1" style="top:298.21pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="B_CX_ES" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">16,614</ix:nonFraction></div><div class="cln fn0 dln" style="top:314.06pt;left:436.96pt;width:30.43pt;"></div><div class="cln fn1" style="top:320.22pt;left:67.73pt;width:292.12pt;">At 30 June 2018</div><div class="crn fn1" style="top:320.22pt;left:359.85pt;width:107.53pt;"><ix:nonFraction contextRef="E_CX_ES" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:PropertyPlantEquipment">17,497</ix:nonFraction></div><div class="cln fn0 dln" style="top:336.07pt;left:436.96pt;width:30.43pt;"></div><div class="clb fn1" style="top:364.25pt;left:46.61pt;width:24.12pt;">5</div><div class="clb fn1" style="top:364.25pt;left:67.73pt;width:231.1pt;">Debtors</div><div class="crb fn1" style="top:375.26pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn1" style="top:375.26pt;left:405.95pt;width:61.43pt;">2018</div><div class="clb fn1" style="top:386.26pt;left:67.73pt;width:174.54pt;">Amounts falling due within one year:</div><div class="crb fn1" style="top:386.26pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn1" style="top:386.26pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn6" style="top:386.26pt;left:468.03pt;width:0.65pt;"></div><div class="cln fn1" style="top:408.27pt;left:67.73pt;width:171.54pt;">Trade debtors</div><div class="crn fn1" style="top:408.27pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_DG_EF" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TradeDebtorsTradeReceivables">199,328</ix:nonFraction></div><div class="crn fn1" style="top:408.27pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_DG_EF" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:TradeDebtorsTradeReceivables">400,719</ix:nonFraction></div><div class="cln fn1" style="top:419.28pt;left:67.73pt;width:171.54pt;">Corporation tax recoverable</div><div class="crn fn1" style="top:419.28pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_DG_EF" decimals="0" scale="0" unitRef="GBP" name="core:CorporationTaxRecoverable">425</ix:nonFraction></div><div class="crn fn1" style="top:419.28pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_DG_EF" decimals="0" scale="0" unitRef="GBP" name="core:CorporationTaxRecoverable">425</ix:nonFraction></div><div class="cln fn1" style="top:430.29pt;left:67.73pt;width:284.66pt;">Amounts owed by group undertakings</div><div class="crn fn1" style="top:430.29pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AmountsOwedByRelatedParties">119,238</ix:nonFraction></div><div class="crn fn1" style="top:430.29pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_DG_EF" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:AmountsOwedByRelatedParties">119,238</ix:nonFraction></div><div class="cln fn1" style="top:441.29pt;left:67.73pt;width:171.54pt;">Other debtors</div><div class="crn fn1" style="top:441.29pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_DG_EF" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherDebtors">671,445</ix:nonFraction></div><div class="crn fn1" style="top:441.29pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_DG_EF" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:OtherDebtors">283,659</ix:nonFraction></div><div class="cln fn0 sln" style="top:457.14pt;left:378.53pt;width:30.43pt;"></div><div class="cln fn0 sln" style="top:457.14pt;left:436.96pt;width:30.43pt;"></div><div class="crn fn1" style="top:463.31pt;left:352.39pt;width:56.56pt;">990,436</div><div class="crn fn1" style="top:463.31pt;left:408.95pt;width:58.43pt;">804,041</div><div class="cln fn0 dln" style="top:479.15pt;left:378.53pt;width:30.43pt;"></div><div class="cln fn0 dln" style="top:479.15pt;left:436.96pt;width:30.43pt;"></div><div class="clb fn1" style="top:507.33pt;left:46.61pt;width:24.12pt;">6</div><div class="clb fn1" style="top:507.33pt;left:67.73pt;width:287.66pt;">Called up share capital</div><div class="crb fn1" style="top:518.34pt;left:349.39pt;width:59.56pt;">2019</div><div class="crb fn1" style="top:518.34pt;left:405.95pt;width:61.43pt;">2018</div><div class="crb fn1" style="top:529.34pt;left:349.39pt;width:59.56pt;">£</div><div class="crb fn1" style="top:529.34pt;left:405.95pt;width:61.43pt;">£</div><div class="cln fn6" style="top:529.34pt;left:468.03pt;width:0.65pt;"></div><div class="clb fn1" style="top:540.35pt;left:67.73pt;width:287.66pt;">Ordinary share capital</div><div class="clb fn1" style="top:551.36pt;left:67.73pt;width:400.78pt;">Issued and fully paid</div><div class="cln fn1" style="top:562.36pt;left:67.73pt;width:228.1pt;"><ix:nonFraction contextRef="B_CV_EW" decimals="0" scale="0" unitRef="Shares" name="core:NumberSharesIssuedFullyPaid">150</ix:nonFraction> <ix:nonNumeric contextRef="C_CV_EW" name="bus:DescriptionShareType">Ordinary shares</ix:nonNumeric> of £<ix:nonFraction contextRef="C_CV_EW" decimals="0" scale="0" unitRef="GBP" name="core:ParValueShare">1</ix:nonFraction> each</div><div class="crn fn1" style="top:562.36pt;left:352.39pt;width:56.56pt;">150</div><div class="crn fn1" style="top:562.36pt;left:408.95pt;width:58.43pt;">150</div><div class="cln fn0 sln" style="top:578.21pt;left:378.53pt;width:30.43pt;"></div><div class="cln fn0 sln" style="top:578.21pt;left:436.96pt;width:30.43pt;"></div><div class="crn fn1" style="top:584.37pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_EG_ET" decimals="0" scale="0" unitRef="GBP" name="core:Equity">150</ix:nonFraction></div><div class="crn fn1" style="top:584.37pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_EG_ET" decimals="0" scale="0" unitRef="GBP" name="core:Equity">150</ix:nonFraction></div><div class="cln fn0 dln" style="top:600.22pt;left:378.53pt;width:30.43pt;"></div><div class="cln fn0 dln" style="top:600.22pt;left:436.96pt;width:30.43pt;"></div></div><div class="portraitPage" style="height:727pt;width:516pt;"><div class="clb fn1" style="top:31.08pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn2" style="top:40.75pt;left:46.61pt;width:423.77pt;"><ix:nonNumeric contextRef="C" name="bus:EntityCurrentLegalOrRegisteredName">VENN HEALTHCARE LIMITED</ix:nonNumeric></div><div class="clb fn2" style="top:54.9pt;left:46.61pt;width:423.77pt;"></div><div class="clb fn3" style="top:69.04pt;left:46.61pt;width:423.77pt;">NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)</div><div class="cln fn4" style="top:80.95pt;left:46.61pt;width:420.77pt;"></div><div class="clbi fn3" style="top:86.91pt;left:46.61pt;width:423.77pt;">FOR THE YEAR ENDED 30 JUNE 2019</div><div class="clb fn1" style="top:98.82pt;left:46.61pt;width:423.77pt;"></div><div class="cln fn0 sln" style="top:108.5pt;left:46.61pt;width:420.77pt;"></div><div class="clb fn1" style="top:121.45pt;left:46.61pt;width:24.12pt;">6</div><div class="clb fn1" style="top:121.45pt;left:67.73pt;width:287.66pt;">Called up share capital</div><div class="crb fn1" style="top:121.45pt;left:378.06pt;width:89.32pt;">(Continued)</div><div class="cln fn0 sln" style="top:695.49pt;left:46.61pt;width:420.77pt;"></div><div class="ccn fn5" style="top:701.96pt;left:46.61pt;width:420.77pt;">- 7 -</div><div class="clb fn1" style="top:144.12pt;left:67.73pt;width:287.66pt;">Preference share capital</div><div class="clb fn1" style="top:155.13pt;left:67.73pt;width:400.78pt;">Issued and fully paid</div><div class="cln fn1" style="top:166.14pt;left:67.73pt;width:228.1pt;"><ix:nonNumeric contextRef="C_CV_EX" name="bus:DescriptionShareType"><ix:nonFraction contextRef="B_CV_EX" decimals="0" scale="0" unitRef="Shares" format="ixt:numcommadot" name="core:NumberSharesIssuedFullyPaid">400,000</ix:nonFraction>&#160;&#160;of £<ix:nonFraction contextRef="C_CV_EX" decimals="0" scale="0" unitRef="GBP" name="core:ParValueShare">1</ix:nonFraction> each</ix:nonNumeric></div><div class="crn fn1" style="top:166.14pt;left:352.39pt;width:56.56pt;">400,000</div><div class="crn fn1" style="top:166.14pt;left:408.95pt;width:58.43pt;">400,000</div><div class="cln fn0 sln" style="top:181.99pt;left:378.53pt;width:30.43pt;"></div><div class="cln fn0 sln" style="top:181.99pt;left:436.96pt;width:30.43pt;"></div><div class="crn fn1" style="top:188.15pt;left:352.39pt;width:56.56pt;"><ix:nonFraction contextRef="B_EG_EU" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">400,000</ix:nonFraction></div><div class="crn fn1" style="top:188.15pt;left:408.95pt;width:58.43pt;"><ix:nonFraction contextRef="E_EG_EU" decimals="0" scale="0" unitRef="GBP" format="ixt:numcommadot" name="core:Equity">400,000</ix:nonFraction></div><div class="cln fn0 dln" style="top:204pt;left:378.53pt;width:30.43pt;"></div><div class="cln fn0 dln" style="top:204pt;left:436.96pt;width:30.43pt;"></div><div class="clb fn1" style="top:232.17pt;left:46.61pt;width:24.12pt;">7</div><div class="clb fn1" style="top:232.17pt;left:67.73pt;width:402.65pt;">Related party transactions</div><div class="cln" style="top:254pt;left:68pt;width:400pt;text-align:justify;font-family:Arial;font-size:7.8pt;"><p style="margin-top:0.00px;margin-bottom:0.00px;text-align:Left;"><span class="fn1">At the year end the company owed £</span><span class="fn1">140,057</span><span class="fn1"> </span><span class="fn1">(2018 - £57) to C Schiel, </span><span class="fn1">the director of the company, in respect of a</span><span class="fn1">n interest free</span><span class="fn1"> loan</span><span class="fn1"> </span><span class="fn1">which is </span><span class="fn1">repayable on demand</span><span class="fn1">.</span></p></div></div><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="B" name="bus:EndDateForPeriodCoveredByReport">2019-06-30</ix:nonNumeric><ix:nonNumeric contextRef="B" name="bus:StartDateForPeriodCoveredByReport">2018-07-01</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityDormantTruefalse">false</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:EntityTradingStatus"></ix:nonNumeric><ix:nonNumeric contextRef="C_EZ_FA" name="bus:LegalFormEntity"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:NameProductionSoftware">CCH Software</ix:nonNumeric><ix:nonNumeric contextRef="C_FB_FC" name="bus:ApplicableLegislation"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:VersionProductionSoftware">CCH Accounts Production 2019.301</ix:nonNumeric><ix:nonNumeric contextRef="C_FD_FE" name="bus:AccountingStandardsApplied"></ix:nonNumeric><ix:nonNumeric contextRef="C_FF_FG" name="bus:AccountsStatusAuditedOrUnaudited"></ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:DescriptionPrincipalActivities">No description of principal activity</ix:nonNumeric><ix:nonNumeric contextRef="C" name="bus:ScopeAccounts"></ix:nonNumeric><ix:nonNumeric contextRef="C_EJ_EK" name="bus:NameEntityOfficer">C Schiel</ix:nonNumeric><ix:nonNumeric contextRef="C_FI_FJ" name="bus:AccountsTypeFullOrAbbreviated"></ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.frc.org.uk/FRS-102/2019-01-01/FRS-102-2019-01-01.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="B"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="F"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-07-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="E"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_CX_ES"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:OtherPropertyPlantEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_CX_ES"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:OtherPropertyPlantEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_DG_EF"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_DG_EF"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:FinancialInstrumentCurrentNon-currentDimension">core:CurrentFinancialInstruments</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_EG_EH"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapital</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_EG_EH"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapital</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_EG_EI"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_EG_EI"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:RetainedEarningsAccumulatedLosses</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_EG_ET"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapitalOrdinaryShares</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_EG_ET"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapitalOrdinaryShares</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_EG_EU"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapitalPreferenceShares</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_EG_EU"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:EquityClassesDimension">core:ShareCapitalPreferenceShares</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_EJ_EK"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityOfficersDimension">bus:Director1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_EM_EN"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:IntangibleAssetClassesDimension">core:IntangibleAssetsOtherThanGoodwill</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_CX_ER"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:ComputerEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="A_EM_EN"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:IntangibleAssetClassesDimension">core:IntangibleAssetsOtherThanGoodwill</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_EM_EN"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:IntangibleAssetClassesDimension">core:IntangibleAssetsOtherThanGoodwill</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="E_EM_EN"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:IntangibleAssetClassesDimension">core:IntangibleAssetsOtherThanGoodwill</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="A_CX_ES"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:OtherPropertyPlantEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_CX_ES"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="core:PropertyPlantEquipmentClassesDimension">core:OtherPropertyPlantEquipment</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_CV_EW"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityShareClassesDimension">bus:OrdinaryShareClass1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_CV_EX"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityShareClassesDimension">bus:PreferenceShareClass1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="B_CV_EW"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityShareClassesDimension">bus:OrdinaryShareClass1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="B_CV_EX"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:EntityShareClassesDimension">bus:PreferenceShareClass1</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_EZ_FA"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:LegalFormEntityDimension">bus:PrivateLimitedCompanyLtd</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_FB_FC"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:ApplicableLegislationDimension">bus:SmallCompaniesRegimeForAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_FD_FE"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountingStandardsDimension">bus:FRS102</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_FF_FG"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsStatusDimension">bus:AuditExempt-NoAccountantsReport</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_FI_FJ"><xbrli:entity><xbrli:identifier scheme="http://www.companieshouse.gov.uk/">09187373</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bus:AccountsTypeDimension">bus:FullAccounts</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="GBP"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit></ix:resources></ix:header></div></body></html>